Clinical Trials Logo

Restlessness clinical trials

View clinical trials related to Restlessness.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02098499 Completed - Nausea Clinical Trials

Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Haloperidol is known to be a safe alternative medication to control difficult pain, and has been shown effective when compared to placebo for controlling headaches. Investigators hypothesized that the combination of haloperidol and diphenhydramine would be a useful medication choice for migraine headache patients in the emergency department in comparison to a common migraine treatment regimen of metoclopramide and diphenhydramine.

NCT ID: NCT01517932 Completed - Pain Clinical Trials

Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia

Start date: June 2011
Phase: Phase 4
Study type: Interventional

Dexmedetomidine is a highly selective α2 adrenoreceptor agonist approved by the US FDA for short-term postoperative sedation and analgesia.It can also reduce the stress response without respiratory depression. In this prospective, randomized, double-blind, placebo-controlled study,we gave dexmedetomidine or saline placebo 1h before operations were over and assessed the effects of dexmedetomidine on stress response and postoperative analgesia in patients undergoing thoracotomy during anesthesia recovery period.

NCT ID: NCT01193816 Completed - Restlessness Clinical Trials

Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning

Sevralox
Start date: May 2011
Phase: Phase 4
Study type: Interventional

This study aims to assess the efficacy of a drug (loxapine, a neuroleptic) in calming patients down in a situation of restlessness during mechanical ventilation weaning. This drug is used for several years to quieten restless patients. Its purpose is to restore spontaneous breathing sooner and therefore to reduce the risks of intubation and mechanical ventilation.

NCT ID: NCT01125579 Completed - Affective Disorders Clinical Trials

Effectiveness of NEURAPAS Balance in Children With Nervous Restlessness

Start date: March 2008
Phase:
Study type: Observational

Purpose: To document data on effectiveness of NEURAPAS® balance (NPB) in the treatment of nervous restlessness in children aged 6 to 12. Each patient is treated with NPB. No placebo group is established. Course and severity of symptoms is documented by a questionnaire on 13 common symptoms of nervous restlessness and a Visual Analogue Scale (VAS). A standardized questionnaire (Parent Child Behaviour Checklist (CBCL/4-18)) is completed. Choice and doses of therapy are at the respective physician's discretion. The planned treatment and observation period is 2 - 4 weeks.